Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
163.00
-19.60 (-10.73%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $91.78 million as of October 8, 2025. Its market cap has increased by 405.01% in one year.
Market Cap
91.78M
Enterprise Value
88.25M
1-Year Change
405.01%
Ranking
Category
Stock Price
$163.00
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $91.78M, a decrease of -75.75%. That is a compound annual growth rate of -24.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 102.81M | 492.67% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.11% |
| Oct 9, 2020 | 378.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |